| 摘要 |
<p>In one aspect, B1,4GaIT -V, an isoform of the enzyme lactosylceramide synthase, is provided as a biomarker for cancer. Also provided are methods and compositions directed at cancers characterized by the overexpression or upregulation of the lactosylceramide synthase isoform B1,4GaIT -V.</p> |
